Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum‐based therapy: DIRECT

BACKGROUND: Cetuximab plus platinum‐based therapy (PBT) followed by cetuximab maintenance until progression (EXTREME) is a guideline‐recommended first‐line treatment option in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). DIRECT (Dose Intensity RElative to CeTuximab)...

Descripción completa

Detalles Bibliográficos
Autores principales: Guigay, Joël, Chamorey, Emmanuel, Lefebvre, Gautier, Rotarski, Maciej, Wagner, Jean‐Philippe, Blot, Emmanuel, Alfonsi, Marc, Seronde, Audrey, Schulten, Jeltje, Peyrade, Frédéric, Le Tourneau, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842698/
https://www.ncbi.nlm.nih.gov/pubmed/34156166
http://dx.doi.org/10.1002/cnr2.1467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842698/
https://www.ncbi.nlm.nih.gov/pubmed/34156166
http://dx.doi.org/10.1002/cnr2.1467

Ejemplares similares